Advertisement

Topics

Euronext N.V Company Profile

17:06 EDT 18th September 2018 | BioPortfolio

Euronext N.V., a holding company incorporated under Dutch law that operates through local subsidiaries, was formed on 22 September 2000 when the exchanges of Amsterdam, Brussels and Paris merged. The Euronext group expanded at the beginning of 2002 with the acquisition of LIFFE (London International Financial Futures and Options Exchange) and the merger with the Portuguese exchange BVLP (Bolsa de Valores de Lisboa e Porto). Today, Euronext is Europe’s leading cross-border exchange, integrating trading and clearing operations on regulated and non-regulated markets for cash products and derivatives. Euronext was formed in 2000 in response to the globalisation of capital markets and to create a pan-European exchange offering its participants increased liquidity and lower transaction costs.

Location

Cannon Bridge House1 Cousin Lane
London
London
EC4R 3XX
United Kingdom

Contact

Phone: 44 20 7623 0444
Email: infolist@euronext.com


News Articles [88 Associated News Articles listed on BioPortfolio]

ERYTECH: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital -February 28, 2018

Article 223-16 of general regulation of French Autorité des Marchés Financiers Regulatory News: ERYTECH (Euronext: ERYP- Nasdaq: ERYP) Listing markets:Euronext Paris from Euronext (Market segment .....

Erytech: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - March 31, 2018

Article 223-16 of general regulation of French Autorité des Marchés Financiers Regulatory News: Erytech (Euronext: ERYP- Nasdaq: ERYP): Listing markets:Euronext Paris from Euronext (Market segment.....

Erytech Pharma S.A.: Monatliche Information bezüglich der Gesamtzahl der Stimmrechte und der Aktien, die das Aktienkapital bilden - 31. August 2018

Artikel 223-16 der allgemeinen Verordnung der französischen Autorité des Marchés FinanciersLyon - Frankreich Notiert an folgenden Märkten: Euronext Paris von Euronext (Marktsegment B - ISIN-Code: ...

NANOBIOTIX Selected to Enter Euronext's Tech 40 Label

Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext: NANO ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that ...

Pharnext SA completes €31mm IPO on Euronext Alternext Stock Exchange

In its initial public offering on the Euronext Alternext Stock Exchange, Pharnext SA (drug repositioning) raised €31mm ($34.2mm) through the sale of 2.9mm shares (2.6mm shares issued as part of a gl...

Ablynx: SANOFI AND ABLYNX ANNOUNCE THE SUCCESSFUL RESULTS OF THE INITIAL TENDER OFFER PERIOD FOR ABLYNX AND COMMENCEMENT OF SQUEEZE-OUT TENDER PERIOD

Paris, France and Ghent, Belgium - May 14, 2018 - Sanofi [Euronext: SAN; NYSE: SNY] and Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced the results of the initial tender offer period o...

Sanofi and Ablynx announce the successful results of the initial tender offer period

Sanofi (Euronext: SAN; NYSE: SNY) and Ablynx (Euronext Brussels and Nasdaq: ABLX) today announced the results of the initial tender offer period of Sanofi's previously announced tender offers to acqui...

Inventiva raises €48m in Euronext IPO

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [57 Associated Companies listed on BioPortfolio]

Euronext N.V

Euronext N.V., a holding company incorporated under Dutch law that operates through local subsidiaries, was formed on 22 September 2000 when the exchanges of Amsterdam, Brussels and Paris merged. The ...

NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trad...

Nutreco Holding N.V.

Nutreco Holding N.V. is an international company in the animal nutrition and fish feed markets, where it seeks to create added value through its knowledge of the food chains. The company has a selecte...

Gemalto

Gemalto (Euronext NL 0000400653 GTO) is the world leader in digital security with 2009 annual revenues of €1.65 billion, and over 10,000 employees operating out of 75 offices...

Galapagos nv

Galapagos was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. From the start, Galapagos has operated a hybrid business model, combining internal discovery programs...

More Information about "Euronext N.V" on BioPortfolio

We have published hundreds of Euronext N.V news stories on BioPortfolio along with dozens of Euronext N.V Clinical Trials and PubMed Articles about Euronext N.V for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Euronext N.V Companies in our database. You can also find out about relevant Euronext N.V Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record